Efficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study

被引：0
|
作者：
Bipin Sethi
Khalid Al-Rubeaan
Mustafa Unubol
Maria A. Mabunay
Baptiste Berthou
Valerie Pilorget
Shireene R. Vethakkan
Gustavo Frechtel
机构：
[1] Care Hospital,Faculty of Medicine
[2] Research and Scientific Center Sultan Bin Abdulaziz Humanitarian City,Hospital de Clínicas
[3] Aydın Adnan Menderes University,undefined
[4] IT&M Stats for Sanofi,undefined
[5] Sanofi,undefined
[6] University Malaya Medical Centre,undefined
[7] Universidad de Buenos Aires,undefined
来源：
Diabetes Therapy | 2022年 / 13卷
关键词：
Basal insulin; Glycaemic control; Hypoglycaemia; Insulin glargine 300 U/mL; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1395 / 1408
页数：13
相关论文
共 50 条
  • [31] Efficacy and safety of insulin glargine 300 U/mL in people with T2D in China: subanalysis of the INITIATION study
    Chen, L.
    Wen, B.
    Liu, H.
    Wu, H.
    Duan, B.
    Shu, H.
    Zhang, Q.
    Zhang, M.
    Li, M.
    Han, Y.
    Kang, L.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [32] EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML (GLA-300) IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES AND RENAL IMPAIRMENT: A SUBGROUP ANALYSIS OF ATOS STUDY
    Tirosh, A.
    Khan, N.
    Vargas-Uricoechea, H.
    Mabunay, M. A. N.
    Coudert, M.
    Pilorget, V.
    Galstyan, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A100 - A101
  • [33] Safety and Efficacy of Insulin Glargine 300 u/mL (Gla-300) Compared with Other Basal or Premixed Insulin Therapies in Patients with Type 2 Diabetes Mellitus (T2DM): A Network Meta-analysis (NMA)
    Freemantle, Nick
    Wang, Hongwei
    Thakur, Deepika
    Stella, Peter
    Chanan, Neha
    Kalra, Manik
    Guillermo, Jasso-Mosqueda Juan
    DIABETES, 2016, 65 : A566 - A566
  • [34] CONFIRM: a comparative effectiveness study of insulin degludec and insulin glargine 300 units/ ml (glargine U300) in insulin-naive patients with type 2 diabetes
    Tibaldi, J.
    Haldrup, S.
    Sandberg, V.
    Wolden, M. L.
    Rodbard, H. W.
    DIABETOLOGIA, 2018, 61 : S44 - S44
  • [35] EASE OF USE OF THE NEW INSULIN GLARGINE 300 U/ML PEN INJECTOR IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES
    Pohlmeier, H.
    Klonoff, D.
    Berard, L.
    Brulle-Wohlhueter, C.
    Wu, J.
    Dahmen, R.
    Nowotny, I.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A18 - A19
  • [36] Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis
    Nakanishi, Shuhei
    Iwamoto, Masahiro
    Kamei, Shinji
    Hirukawa, Hidenori
    Shimoda, Masashi
    Tatsumi, Fuminori
    Kohara, Kenji
    Obata, Atsushi
    Kimura, Tomohiko
    Kinoshita, Tomoe
    Irie, Shintaro
    Sanada, Junpei
    Fushimi, Yoshiro
    Nishioka, Momoyo
    Mizoguchi, Akiko
    Kameyama, Miyuki
    Mune, Tomoatsu
    Kaku, Kohei
    Kaneto, Hideaki
    INTERNAL MEDICINE, 2018, 57 (10) : 1381 - 1389
  • [37] Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice
    Hidvegi, Tibor
    Balogh, Zoltan
    Vass, Viktor
    Kovacs, Gabor
    Stella, Peter
    DIABETES THERAPY, 2020, 11 (02) : 467 - 478
  • [38] Efficacy and Safety of Oral Basal Insulin: Eight-Week Feasibility Study in People with Type 2 Diabetes (T2DM)
    Plum-Moerschel, Leona
    Heise, Tim
    Zijlstra, Eric
    Lyby, Karsten
    Wassermann, Karsten
    Brondsted, Lise
    Halberg, Inge Birk
    DIABETES, 2017, 66 : A100 - A100
  • [39] Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice
    Tibor Hidvégi
    Zoltán Balogh
    Viktor Vass
    Gábor Kovács
    Péter Stella
    Diabetes Therapy, 2020, 11 : 467 - 478
  • [40] Improved real-world outcomes for type 2 diabetes patients on basal-bolus insulin therapy switching to insulin glargine 300 U/ml vs. insulin glargine 100 U/ml and insulin Detemir
    Wu, Jasmanda
    Bailey, Timothy S.
    Bosnyak, Zsolt
    Westerbacka, Jukka
    Gupta, Rishab A.
    Menon, Arjun A.
    Nicholls, Charlie
    Blonde, Lawrence
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 416 - 417
12345